EHC vs ACHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACHC Captures Institutional Edge (3โ1 Pillars ยท 3โ7 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Healthcare Company, Inc. (ACHC) driven by superior Valuation, Momentum & Technical, Options & Structure while EHC counters with relative strength in Growth & Margin. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus ACHC at 17.0x Forward P/E and 9.8% operating margin (+5.1% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against ACHC sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EHC Revenue | ACHC Revenue | EHC Op. Margin | ACHC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $4.28B | $1.90B | 13.0% | 31.2% | ACHC |
| FY2019 | $4.61B | $2.01B | 13.3% | 29.2% | ACHC |
| FY2020 | $3.57B | $2.09B | 15.8% | -32.2% | EHC |
| FY2021 | $4.01B | $2.31B | 13.9% | 8.2% | EHC |
| FY2022 | $4.35B | $2.61B | 12.4% | 10.5% | EHC |
| FY2023 | $4.80B | $2.93B | 7.3% | -0.7% | EHC |
| FY2024 | $5.37B | $3.15B | 8.5% | 8.1% | EHC |
| FY2025 | $5.94B | $3.31B | 9.5% | -33.3% | EHC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | ACHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $3.2B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 21.2x | 16.9x | Lower Multiple | ACHC |
| Forward P/E Ratio Valuation | 19.4x | 17.0x | Lower Multiple | ACHC |
| Revenue Growth (YoY) Growth | +8.9% | +5.1% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 18.4% | 9.8% | Higher Margin | EHC |
| Net Profit Margin Profitability | 10.2% | -33.1% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 25.1% | -40.5% | Higher ROE | EHC |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 82% ($11โ$40) | Stronger Trend | ACHC |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 1.00ฮฒ ยท 61% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 33.1 / 100 (SELL) | Higher Composite | EHC |